Log in to search using one of your social media accounts:

 

Scientists Race to Regrow Lost Knee Cartilage Scientists Race to Regrow Lost Knee Cartilage
About 14 million Americans have osteoarthritis of the knees severe enough to cause pain and inflammation, according to the Arthritis Foundation, and more people are getting the condition -- also known as OA -- as they age.WebMD Health News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 13, 2017 Category: Consumer Health News Tags: Rheumatology News Source Type: news

3-D knees: Memphis surgeon using innovative tech for knee replacements
Memphian Gail Blayde was suffering from end-state osteoarthritis of both of her knees when she was presented with an interesting opportunity. She could have replacements custom-made for her using a special 3-D printer. Blayde had her first knee replacement surgery, on her right knee, in June. After being "very pleased" with the results, she opted for surgery on her other knee in August. "I was on a cane, walker and wheelchair before ," Blayde said. "I'm getting back to where I can walk freely.… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - December 13, 2017 Category: American Health Authors: Elle Perry Source Type: news

AAOS approves diagnostic and treatment criteria for osteoarthritis of the hip
(American Academy of Orthopaedic Surgeons) The American Academy of Orthopaedic Surgeons (AAOS) Board of Directors approved new Appropriate Use Criteria (AUC) for Management of Osteoarthritis of the Hip. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 12, 2017 Category: International Medicine & Public Health Source Type: news

Osteoarthritis: Doing THIS regularly could protect your joints as you age
MIDDLE aged women who do some regular form of exercise help protect their joints as they age, a new study found. (Source: Daily Express - Health)
Source: Daily Express - Health - December 6, 2017 Category: Consumer Health News Source Type: news

The effect of primary total knee arthroplasty on the incidence of falls and balance-related functions in patients with osteoarthritis - Si HB, Zeng Y, Zhong J, Zhou ZK, Lu YR, Cheng JQ, Ning N, Shen B.
This study investigated the incidence of falls, balance-related outcomes and risk factors for falls before and after primary total knee arthroplasty (TKA). Three hundr... (Source: SafetyLit)
Source: SafetyLit - December 2, 2017 Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news

Flexion CEO: Setting Zilretta up to succeed with a history lesson
Locally acting therapies are like a religion to Flexion Therapeutics (NSDQ:FLXN) co-founder & CEO Dr. Mike Clayman, who spent decades at Eli Lilly (NYSE:LLY) with the company’s co-founder, Dr. Neil Bodick, watching promising compounds fail in late-stage trials on the heels of unanticipated safety results. “That’s part of the reason, not the whole reason but part of the reason, why the industry only has a 60% success rate in Phase III, because you can’t predict what safety’s going to look like if you’re giving a systemically-administered product that has the potent...
Source: Mass Device - December 1, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Drug-Device Combinations Food & Drug Administration (FDA) Orthopedics Pain Management Pharmaceuticals Wall Street Beat Eli Lilly & Co. Flexion Therapeutics Genzyme Corp. Source Type: news

Losing weight by exercise alone does not protect knees
Losing weight through both diet and exercise is better for the knees than exercise alone Related items fromOnMedica Fibre-rich diet linked to lowered risk of painful knee osteoarthritis EU must do more to tackle obesity ‘epidemic’ Weight gain linked to cancer risk Real food and brisk daily walk best for heart health (Source: OnMedica Latest News)
Source: OnMedica Latest News - November 28, 2017 Category: UK Health Source Type: news

FDA Warns About Serious Risks with " Medical Food " for Osteoarthritis
Used of Limbrel — a flavonoid capsule intended to manage the metabolic processes associated with osteoarthritis — is linked to potentially life-threatening conditions, the FDA warned... (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - November 27, 2017 Category: Primary Care Source Type: news

Flavocoxid for OA Tied to Life-Threatening Health Problems Flavocoxid for OA Tied to Life-Threatening Health Problems
The FDA says several adverse events, including drug-induced liver injury and hypersensitivity pneumonitis, have been linked to flavocoxid, a medical food product marketed for osteoarthritis (OA).News Alerts (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 27, 2017 Category: Consumer Health News Tags: Rheumatology News Alert Source Type: news

Scientists Race To Regrow Lost Knee Cartilage
Different researchers are all seeking the same goal: A way to reverse the loss of cartilage in the knee, a painful condition that causes osteoarthritis. (Source: WebMD Health)
Source: WebMD Health - November 27, 2017 Category: Consumer Health News Source Type: news

Is Outpatient Knee Replacement for You? Know Who Benefits
Treatment TermsKnee replacement surgery Author Shawn Lake Overview Duke orthopaedic surgeons now offer some people who need knee replacement surgery the option to go home a few hours after the procedure. According to Michael Bolognesi, MD, an orthopaedic surgeon at Duke who specializes in hip and knee replacement, the experience has been “overwhelmingly positive.” Content Blocks Header Who Needs Knee Replacement Surgery? ContentMore than 600,000  knee replacement surgeries  are performed each year, making it one of the most the most common  orthopaedic surgeries in the U.S. The proce...
Source: dukehealth.org: Duke Health News - November 27, 2017 Category: Consumer Health News Authors: dg62 at duke.edu Source Type: news

3D-printed implants and scaffold technology – how bioengineering innovation could treat and prevent osteoarthritis
The need for new and effective ways to treat and preventosteoarthritis has never been more urgent. Demand for total joint replacements is rising every year, and expected to double by 2030, placing a huge strain on the NHS. Meanwhile, those living with the pain of early stage osteoarthritis or at risk of developing it due to injury face limited treatment options.That’s why Arthritis Research UK is investing in innovative research dedicated to developing medical technologies which could provide an answer. By 'medical technologies' we mean cutting-edge medical devices, orthotics, implants and imaging techniques, harness...
Source: Arthritis Research UK - November 23, 2017 Category: Rheumatology Source Type: news

Arthritis Didn't Afflict Famed Clone Sheep, Experts Say
THURSDAY, Nov. 23, 2017 -- Dolly the sheep did not have early onset osteoarthritis after all, according to new research. Experts at the University of Glasgow and the University of Nottingham in the United Kingdom said their findings dispel original... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - November 23, 2017 Category: General Medicine Source Type: news

Radiographs of Dolly's skeleton show no signs of abnormal osteoarthritis
(University of Nottingham) Original concerns that cloning caused early-onset osteoarthritis in Dolly the sheep are unfounded, say experts at the University of Nottingham and the University of Glasgow.The team, who published last year's Nottingham Dollies research which showed that the 8 year-old Nottingham 'Dollies' had aged normally, have now published a radiographic assessment of the skeletons of Dolly herself, Bonnie (her naturally conceived daughter) and Megan and Morag (the first two animals to be cloned from differentiated cells). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 23, 2017 Category: International Medicine & Public Health Source Type: news

Ampio Announces Publication of Ampion(TM) Treatment of Severe Osteoarthritis of the Knee as a Feature Article in Orthopedics Peer-Reviewed Journal
ENGLEWOOD, Colo., Nov. 22, 2017 -- (Healthcare Sales & Marketing Network) -- Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announced that a manuscript entitled: "LMWF-5A for the Treatment of Severe Osteoarthritis of the Knee: Integrated Analysis... Biopharmaceuticals, Orthopaedic Ampio Pharmaceuticals, osteoarthritis, Ampion (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 22, 2017 Category: Pharmaceuticals Source Type: news

Opioid Use for Osteoarthritis Is Prevalent
A large percentage of patients with advanced knee, hip, or spine OA take opioids for their chronic pain. (Source: ConsultantLive)
Source: ConsultantLive - November 22, 2017 Category: Internal Medicine Authors: Gregory M. Weiss, M.D. Tags: Osteoarthritis Pain Pain Management Source Type: news

FDA Warns About Serious Risks with "Medical Food" for Osteoarthritis
Used of Limbrel — a flavonoid capsule intended to manage the metabolic processes associated with osteoarthritis — is linked to potentially life-threatening conditions, the FDA warned... (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - November 21, 2017 Category: Primary Care Source Type: news

Opioid Use for Osteoarthritis Is Prevalent
A large percentage of patients with advanced knee, hip, or spine OA take opioids for their chronic pain. (Source: CancerNetwork)
Source: CancerNetwork - November 21, 2017 Category: Cancer & Oncology Authors: Gregory M. Weiss, M.D. Tags: Osteoarthritis Pain Pain Management Source Type: news

After FDA nod, Flexion launches osteoarthritis injection
Flexion Therapeutics (NSDQ:FLXN) today launched its Zilretta therapy designed to help patients manage pain associated with osteoarthritis of the knee. The Burlington, Mass.-based company’s extended-release intra-articular injection combines a commonly administered, short-acting corticosteroid with a polylactic-co-glycolic acid matrix using Flexion’s microsphere technology. Get the full story at our sister site, Drug Delivery Business News. The post After FDA nod, Flexion launches osteoarthritis injection appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - November 20, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Drug-Device Combinations Food & Drug Administration (FDA) Orthopedics Pain Management Pharmaceuticals Wall Street Beat Flexion Therapeutics Source Type: news

Osteoarthritis patients 'negatively affected by a fear of movement'
People with kneeosteoarthritis are experiencing a decreased quality of life due to a fear of movement associated with the condition. This is according to a new US study carried out by the University of North Carolina at Chapel Hill, which has indicated that this fear of movement may be causing those with osteoarthritis to lead less active lifestyles, putting them at risk of their conditions worsening. Factors affecting fear of movement For this study, a total of 350 participants taking part in a clinical trial were asked to evaluate their fear of movement, as well as providing details on their age, sex, race, education,pai...
Source: Arthritis Research UK - November 15, 2017 Category: Rheumatology Source Type: news

Drug hope for severe hand pain in osteoarthritis patients
The debilitating hand pain often experienced by osteoarthritis patients can be successfully treated with a drug normally used for epilepsy, anxiety and neuropathic pain, according to UK researchers. (Source: Nursing Times)
Source: Nursing Times - November 13, 2017 Category: Nursing Source Type: news

A personalised approach to chronic knee problems
Knee osteoarthritis is a chronic musculoskeletal disorder that affects over eight million people in the EU. The EU-funded KNEEMO project is developing a unique personalised approach to treatment and training a new generation of biomechanical specialists. (Source: EUROPA - Research Information Centre)
Source: EUROPA - Research Information Centre - November 13, 2017 Category: Research Source Type: news

New York Times (NYT) article looks at OA risk after knee ligament tear and ACL reconstruction
An article in The New York Times (NYT) discusses anterior cruciate ligament (ACL) repair and an increased likelihood of developing osteoarthritis (OA). (Source: Orthogate - Latest News)
Source: Orthogate - Latest News - November 11, 2017 Category: Orthopaedics Tags: Featured Editors Choice News Source Type: news

Cooled radiofrequency ablation (CRFA) may be effective therapy for patients with knee OA pain
Data from a study published online in the journal Regional Anesthesia & Pain Medicine suggest that, compared with intra-articular steroid (IAS) injection, cooled radiofrequency ablation (CRFA) may be an effective therapy for patients with knee osteoarthritis (OA) pain.  (Source: Orthogate - Latest News)
Source: Orthogate - Latest News - November 11, 2017 Category: Orthopaedics Tags: Featured Editors Choice News Source Type: news

Synthetic cannabis gel that can relieve arthritis  
The clear gel, ZYN002, is a synthetic form of a compound in the plant. It is currently undergoing trials U.S. patients and initial tests suggest it can soothe the agony of osteoarthritis of the knee. (Source: the Mail online | Health)
Source: the Mail online | Health - November 7, 2017 Category: Consumer Health News Source Type: news

Former cricketers 'more likely to experience osteoarthritis and joint surgery'
Elite-level cricketers are more likely than most to experience osteoarthritis and other related bone health issues, according to new research. The University of Oxford-led study, which was supported by theArthritis Research UK Centre for Sport,Exercise andOsteoarthritis* and the England and Wales Cricket Board, has offered evidence that more needs to be done to monitor and address the specific health risks associated with the sport, and to offer tailored support for those in need. The impact of cricket on musculoskeletal health For this research, a group of 113 former elite cricket players were asked to complete a health q...
Source: Arthritis Research UK - November 7, 2017 Category: Rheumatology Source Type: news

Spine osteoarthritis patients & those under 65 more likely to use opioids to manage pain
(American College of Rheumatology) A large percentage of patients with end-stage knee, hip and spine osteoarthritis use opioids to manage their chronic pain, especially those who are younger or have symptoms of depression, according to new research findings presented this week at the 2017 ACR/ARHP Annual Meeting in San Diego. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - November 4, 2017 Category: International Medicine & Public Health Source Type: news

Retired professional footballers at higher risk of knee osteoarthritis
Retired professional footballers are far more prone to develop knee pain and osteoarthritis and face problems with their knees earlier in life than the average person, a study has revealed.The research was led by academics at The University of Nottingham and funded by Arthritis Research UK with collaborative support from FMARC (FIFA’s Medical and Research Centre), the Professional Footballers Association (PFA) and SPIRE Healthcare Group.The study reported that male ex-footballers were two to three times more likely to suffer from knee pain and knee osteoarthritis and require a total knee replacement, even after ...
Source: Arthritis Research UK - November 3, 2017 Category: Rheumatology Source Type: news

Noninvasive procedure is superior to steroid injection for painful knee osteoarthritis
(Wolters Kluwer Health) For patients with osteoarthritis of the knee, a minimally invasive procedure called cooled radiofrequency ablation (CRFA) provides better pain reduction and functional improvement compared to steroid injection of the knee, concludes a study in Regional Anesthesia& Pain Medicine, published by Wolters Kluwer. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 2, 2017 Category: International Medicine & Public Health Source Type: news

Myoscience launches Iovera TKA pain management, opioid reduction trial
Myoscience said today it launched a clinical trial aiming to investigate its Iovera pain management system in treating post-surgical knee patients, with the 1st patient enrolled at Memphis, Tenn.’s Campbell Clinic. The Fremont, Calif.-based company’s Iovera technology is a non-opioid and non-systemic treatment designed to block pain signals from the peripheral nerves. Myoscience said the Iovera treatment uses the body’s natural response to cold to treat peripheral nerves, causing a sensory nerve to stop sending pain signals after receiving targeted cold therapy that is part of the treatment. The effect is...
Source: Mass Device - October 26, 2017 Category: Medical Devices Authors: Fink Densford Tags: Clinical Trials Orthopedics Pain Management Myoscience Source Type: news

Do Older Women Who Use Bisphosphonates Need Fewer Knee Replacements? Do Older Women Who Use Bisphosphonates Need Fewer Knee Replacements?
The rate of knee replacement surgery among older women with knee osteoarthritis is lower in those who take bisphosphonates than in those who don't, according to a database study.Reuters Health Information (Source: Medscape Orthopaedics Headlines)
Source: Medscape Orthopaedics Headlines - October 20, 2017 Category: Orthopaedics Tags: Orthopaedics News Source Type: news

Robotic knee replacement: Mayo Clinic Radio Health Minute
America's aging population has created a steadily increasing demand for?knee replacement?surgeries.?Osteoarthritis?is the most common reason knee joints wear out. It's a condition that becomes more prevalent with age. In this Mayo Clinic Radio Health Minute?Dr. Cedric Ortiguera?explains how the precision of robotic assistance in surgery is expanding the patient population that can be helped. To [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - October 20, 2017 Category: Databases & Libraries Source Type: news

Zoo cure heals humans
One of the highlights of my trip to Tanzania in 2012 was visiting the Ngorongoro Crater and Conservation Area. They have the largest lions on the planet. I got very close as part of my invitation by the director of park services. Along with elephants, lions, gazelles and zebras, I got to see wildebeest, the almost-extinct black rhino and giraffes. I was lucky enough to photograph this giraffe on my trip to Ngorongoro Crater in Tanzania. I am always awed when I see these magnificent creatures in their native environment. They thrive the same way they did thousands of years ago. But when these animals are tak...
Source: Al Sears, MD Natural Remedies - October 19, 2017 Category: Complementary Medicine Authors: Cathy Card Tags: Anti-Aging Source Type: news

Arthritis symptoms: THREE unlikely signs of the joint condition REVEALED
ARTHRITIS symptoms are commonly thought of as joint pain and swelling, but noisy joints, muscle loss and dry eyes can also be signs you ’re suffering from rheumatoid arthritis or osteoarthritis. (Source: Daily Express - Health)
Source: Daily Express - Health - October 19, 2017 Category: Consumer Health News Source Type: news

THE Partial Knee Meeting
THE Partial Knee meeting will, in a cycle of two years, happen in Belgium and will discuss arthroplasty solutions that are not total joint replacements, but all other type of combinations of resurfacing solutions for knee osteoarthritis.   (Source: Orthogate - Latest News)
Source: Orthogate - Latest News - October 18, 2017 Category: Orthopaedics Tags: Featured Meetings Events Source Type: news

Africa:What Tracing a Tough Commute in Ancient Egypt Reveals About Osteoarthritis
[The Conversation Africa] Osteoarthritis is a disease that is millions of years old. Researchers have even found evidence for osteoarthritis in dinosaurs. It's also one of the most prevalent diseases to impact our bones - and its rates will only grow with an ageing population worldwide. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - October 18, 2017 Category: African Health Source Type: news

FDA OKs trial for MiMedx AmnioFix knee treatment, prelims
MiMedx (NSDQ:MDXG) saw shares rise today after announcing 3rd quarter revenue that beat consensus on The Street alongside FDA approval to proceed with the Investigational New Drug phase 2B study of its AmnioFix injectable product. The Marietta, Ga.-based company said it expects to post sales of $84.6 million for its 3rd quarter, well ahead of both its guidance of between $70 and $80 million and Wall Street consensus of $80.1 million. Revenue for MiMedx grew 31% compared to sales from the 3rd quarter of the previous year, according to an SEC filing. “Our third quarter revenue performance was very strong, and we a...
Source: Mass Device - October 17, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Clinical Trials MiMedx Group Inc. Source Type: news

Anika ’ s Monovisc therapy gets green light in Australia
Anika Therapeutics (NSDQ:ANIK) said yesterday that regulatory authorities in Australia approved the company’s single injection viscosupplement, Monovisc, for the treatment of pain associated with osteoarthritis of the synovial joints. This latest regulatory win means that Monovisc is commercially available in more than twenty countries, including the U.S. and Canada. The Bedford, Mass.-based company said it plans to move into additional international markets next year with its therapy for hip and knee pain. Get the full story at our sister site, Drug Delivery Business News. The post Anika’s Monovisc therap...
Source: Mass Device - October 17, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Drug-Device Combinations Orthopedics Pain Management Pharmaceuticals Regulatory/Compliance Wall Street Beat Anika Therapeutics Inc. Source Type: news

Unique Aquatic Therapy Beneficial in Knee Osteoarthritis
No abstract available (Source: Lippincott's Bone and Joint Newsletter)
Source: Lippincott's Bone and Joint Newsletter - October 17, 2017 Category: Orthopaedics Tags: CME Article Source Type: news

Arthritis: THIS supplement could help osteoarthritis symptoms including joint pain
ARTHRITIS symptoms, including joint pain, could be reduced by taking this pine bark supplement. (Source: Daily Express - Health)
Source: Daily Express - Health - October 16, 2017 Category: Consumer Health News Source Type: news

Autologous Protein Solution (APS) may reduce pain and improve function in patients affected by knee OA
Findings from a study published online in The American Journal of Sports Medicine suggest that a single injection of autologous protein solution (APS) may help reduce pain for patients with knee osteoarthritis (OA).  (Source: Orthogate - Latest News)
Source: Orthogate - Latest News - October 15, 2017 Category: Orthopaedics Tags: Featured Editors Choice News Source Type: news

Arthritis warning: Doing THESE three activities can increase risk of knee osteoarthritis
ARTHRITIS is inflammation of the joint, and osteoarthritis of the knee can cause severe pain and affect quality of life. Don ’t overdo these three positions. (Source: Daily Express - Health)
Source: Daily Express - Health - October 13, 2017 Category: Consumer Health News Source Type: news

Association between MRI-defined osteoarthritis, pain, function and strength 3-10 years following knee joint injury in youth sport - Whittaker JL, Toomey CM, Woodhouse LJ, Jaremko JL, Nettel-Aguirre A, Emery CA.
BACKGROUND: Youth and young adults who participate in sport have an increased risk of knee injury and subsequent osteoarthritis. Improved understanding of the relationship between structural and clinical outcomes postinjury could inform targeted osteoarthr... (Source: SafetyLit)
Source: SafetyLit - October 13, 2017 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

Why did a Colorado biotech's shares jump 26 percent Thursday?
Why did shares in Ampio Pharmaceuticals Inc. jump more than 26 percent in Thursday trading? Probably because the Douglas County-based biotech (NYSE: AMPE) released good news on its drug to treat pain caused from knee osteoarthritis. Ampion said "LMWF-5A For The Treatment Of Severe Osteoarthritis Of The Knee: Integrated Analysis Of Safety And Efficacy" was accepted for publication in "O rthopedics," an international peer-reviewed journal in the field of orthopedics. "These results are clinically… (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - October 13, 2017 Category: Health Management Authors: Ben Miller Source Type: news

Why did a Colorado biotech's shares jump 26 percent Thursday?
Why did shares in Ampio Pharmaceuticals Inc. jump more than 26 percent in Thursday trading? Probably because the Douglas County-based biotech (NYSE: AMPE) released good news on its drug to treat pain caused from knee osteoarthritis. Ampion said "LMWF-5A For The Treatment Of Severe Osteoarthritis Of The Knee: Integrated Analysis Of Safety And Efficacy" was accepted for publication in "O rthopedics," an international peer-reviewed journal in the field of orthopedics. "These results are clinically… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - October 13, 2017 Category: Biotechnology Authors: Ben Miller Source Type: news

Former rugby union players 'at greater risk of arthritis'
This study provides information for those who play the sport on the short and long-term risks and benefits associated with rugby. It is also hoped that further studies, building on this work, will generate better preventative advice and treatment for both professional and recreational sports players." (Source: Arthritis Research UK)
Source: Arthritis Research UK - October 11, 2017 Category: Rheumatology Source Type: news

Acupuncture could ease women's vulvar pain
(University of Illinois at Chicago) Acupuncture has been successfully used to treat such ailments as back and neck pain, osteoarthritis and headaches. Judith Schlaeger is working to discover whether it can help the up to 14 million American women who experience genital pain. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 11, 2017 Category: International Medicine & Public Health Source Type: news

US FDA approves Flexion ’s Zilretta to treat osteoarthritis knee pain
The US Food and Drug Administration (FDA) has granted approval for specialist pharmaceutical firm Flexion Therapeutics ’s Zilretta for the treatment of osteoarthritis (OA) knee pain. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - October 9, 2017 Category: Pharmaceuticals Source Type: news

MATT ROBERTS: Help me find a trainer for my bad back
A man in his 50s asks MATT ROBERTS about the best personal trainer to help his fitness despite suffering from lower back problems as well as osteoarthritis in his knees and neck. (Source: the Mail online | Health)
Source: the Mail online | Health - October 8, 2017 Category: Consumer Health News Source Type: news

Flexion's knee pain drug gets FDA nod, shares hit life high
(Reuters) - Flexion Therapeutics Inc said its injectable drug to treat osteoarthritis-related knee pain was approved by the U.S. Food and Drug Administration, sending the drug developer's shares soaring to a record high in regular trading on Friday. (Source: Reuters: Health)
Source: Reuters: Health - October 6, 2017 Category: Consumer Health News Tags: healthNews Source Type: news